anmeldenNovo Nordisk Aktie
39,41
EUR
+0,05
EUR
+0,13
%
39,32
EUR
-0,08
EUR
-0,20
%
Novo Nordisk jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Marktkap. 174,76 Mrd. EUR
KGV 14,11 Div. Rendite 3,60%WKN A3EU6F
ISIN DK0062498333
Symbol NONOF
AI Analyse
Werbung
Novo Nordisk Aktie Analyse
| 24.05.17 | Novo Nordisk buy | Deutsche Bank AG | |
| 04.05.17 | Novo Nordisk buy | UBS AG | |
| 04.05.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 03.05.17 | Novo Nordisk buy | UBS AG | |
| 28.04.17 | Novo Nordisk buy | UBS AG | |
| 11.04.17 | Novo Nordisk buy | Deutsche Bank AG | |
| 09.03.17 | Novo Nordisk buy | UBS AG | |
| 02.03.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 28.02.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 16.02.17 | Novo Nordisk buy | UBS AG | |
| 03.02.17 | Novo Nordisk buy | Deutsche Bank AG | |
| 03.02.17 | Novo Nordisk buy | UBS AG | |
| 03.02.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 30.01.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 24.01.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 23.01.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 19.01.17 | Novo Nordisk buy | UBS AG | |
| 09.01.17 | Novo Nordisk buy | Deutsche Bank AG | |
| 06.12.16 | Novo Nordisk buy | UBS AG | |
| 30.11.16 | Novo Nordisk buy | Deutsche Bank AG | |
| 30.11.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 07.11.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 01.11.16 | Novo Nordisk buy | Deutsche Bank AG | |
| 31.10.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 27.10.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 30.09.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 16.09.16 | Novo Nordisk buy | Citigroup Corp. | |
| 14.09.16 | Novo Nordisk Outperform | BNP PARIBAS | |
| 05.09.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 02.09.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 02.09.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 22.08.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 09.08.16 | Novo Nordisk buy | Citigroup Corp. | |
| 09.08.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 08.08.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 02.08.16 | Novo Nordisk buy | Citigroup Corp. | |
| 01.08.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 27.07.16 | Novo Nordisk buy | Citigroup Corp. | |
| 25.07.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 13.07.16 | Novo Nordisk overweight | Morgan Stanley | |
| 13.07.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 29.06.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.06.16 | Novo Nordisk buy | Citigroup Corp. | |
| 15.06.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 14.06.16 | Novo Nordisk buy | Citigroup Corp. | |
| 14.06.16 | Novo Nordisk Conviction Buy | Goldman Sachs Group Inc. | |
| 13.06.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 09.06.16 | Novo Nordisk overweight | Morgan Stanley | |
| 09.06.16 | Novo Nordisk buy | Baader Wertpapierhandelsbank | |
| 26.05.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
Werbung
Werbung
